CONMED Corporation
CNMD
$54.99
-$0.82-1.47%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.09% | 2.88% | 5.78% | 3.98% | 4.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.09% | 2.88% | 5.78% | 3.98% | 4.55% |
| Cost of Revenue | 3.81% | 1.01% | 3.38% | 2.52% | 2.49% |
| Gross Profit | 2.50% | 4.37% | 7.63% | 5.13% | 6.27% |
| SG&A Expenses | 5.05% | 11.54% | 2.60% | 3.80% | 0.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.19% | 5.58% | 2.57% | 3.39% | 1.74% |
| Operating Income | -5.38% | -22.43% | 27.47% | 8.42% | 32.45% |
| Income Before Tax | -20.25% | -69.82% | 7.27% | 178.36% | 115.34% |
| Income Tax Expenses | 12.74% | -71.35% | 29.89% | 68.11% | 104.34% |
| Earnings from Continuing Operations | -28.54% | -69.37% | 2.07% | 209.30% | 118.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.54% | -69.37% | 2.07% | 209.30% | 118.29% |
| EBIT | -5.38% | -22.43% | 27.47% | 8.42% | 32.45% |
| EBITDA | -2.37% | -13.58% | 20.33% | 5.80% | 19.52% |
| EPS Basic | -28.85% | -69.56% | 1.53% | 208.13% | 117.19% |
| Normalized Basic EPS | -2.91% | -27.00% | 36.72% | 14.27% | 50.89% |
| EPS Diluted | -28.13% | -69.84% | 2.79% | 214.00% | 123.26% |
| Normalized Diluted EPS | -2.31% | -26.26% | 39.03% | 16.82% | 54.99% |
| Average Basic Shares Outstanding | 0.44% | 0.63% | 0.54% | 0.37% | 0.49% |
| Average Diluted Shares Outstanding | -0.17% | -0.39% | -1.13% | -1.82% | -2.17% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.41% | 2.28% | -0.02% | -0.68% | -0.54% |